H. Halliday

发表

Echographic ventricular systolic time intervals in normal term and preterm neonates.

A. Fanaroff, J. Liebman, H. Halliday, 1978, Pediatrics.

Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?

H. Halliday, B. Robertson, C. Speer, 2000, Acta paediatrica.

Principles of surfactant replacement.

H. Halliday, B. Robertson, B. Robertson, 1998, Biochimica et biophysica acta.

Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.

H. Halliday, 2001, The Journal of pediatrics.

Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome.

H. Halliday, B. Robertson, T. Curstedt, 1988, Archives of disease in childhood.

Cerebral arteriovenous malformation in a neonate: treatment by embolisation.

M. Shields, H. Halliday, G. Mcclure, 1987, Archives of disease in childhood.

Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.

J. Corcoran, H. Halliday, B. Robertson, 1994, Archives of disease in childhood. Fetal and neonatal edition.

[European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update].

G. Greisen, M. Hallman, V. Carnielli, 2014, Zhonghua er ke za zhi = Chinese journal of pediatrics.

Elective delivery at “term”: implications for the newborn

H. Halliday, 1999, Acta paediatrica.

Respiratory distress syndrome: echocardiographic assessment of cardiovascular function and pulmonary vascular resistance.

A. Fanaroff, J. Liebman, H. Halliday, 1977, Pediatrics.

Echocardiographic findings of large patent ductus arteriosus in the very low birthweight infant before and after treatment with indomethacin.

J. Brady, H. Halliday, T. Hirata, 1979, Archives of disease in childhood.

Cerebral blood flow velocity changes after rapid administration of surfactant.

H. Halliday, B. Robertson, 1992, Archives of disease in childhood.

European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants – 2010 Update

G. Greisen, E. Özek, M. Hallman, 2010, Neonatology.

[European consensus guidelines on the management of neonatal respiratory distress syndrome].

G. Greisen, V. Carnielli, U. Simeoni, 2008, Zhonghua er ke za zhi = Chinese journal of pediatrics.

Reduction in the risk of bronchopulmonary dysplasia from 1980–1990: Results of a multivariate logistic regression analysis

J. Corcoran, C. Patterson, H. Halliday, 1993, European Journal of Pediatrics.

Synthetic or natural surfactants

H. Halliday, 1997, Acta paediatrica.

A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome

D. Strayer, S. Parmigiani, L. Gaioni, 1992, European Journal of Pediatrics.

Percutaneous central venous catheter use in the very low birth weight neonate

H. Halliday, P. Cairns, B. McClure, 1995, European Journal of Pediatrics.

Indomethacin therapy for large patent ductus arteriosus in the very low birth weight infant: results and complications.

J. Brady, H. Halliday, T. Hirata, 1979, Pediatrics.

Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: The INNOVO Multicentre Randomised Controlled Trial (ISRCTN 17821339)

J. Stocks, R. Grieve, D. Elbourne, 2005, Pediatrics.

The role of matrix metalloproteinases ‐9 and ‐2 in development of neonatal chronic lung disease

A. Curley, J. Warner, H. Halliday, 2004, Acta paediatrica.

Surfactant replacement therapy for severe neonatal respiratory distress syndrome: implications for nursing care.

H. Halliday, R. Tubman, N. Sittlington, 1991, Midwifery.

Continuous positive airway pressure.

H. Halliday, 1993, Acta paediatrica.

Treatment strategies for bronchopulmonary dysplasia with postnatal corticosteroids in Europe: the EURAIL survey *

O. Saugstad, P. Truffert, H. Halliday, 2003, Acta paediatrica.

O-006 Follow – Up Outcomes From The Boost-ii Uk Trial Of Oxygen Saturation Targeting In Preterm Infants

N. Marlow, E. Juszczak, P. Brocklehurst, 2014, Archives of Disease in Childhood.

Unusual site for oesophageal perforation in an extremely low birth weight infant

H. Halliday, H. Halliday, P. Cairns, 1999, European Journal of Pediatrics.

Postnatal dexamethasone: what is the real cost‐benefit ratio?

H. Halliday, 2003 .

Echocardiographic findings oflarge patent ductus arteriosus intheverylowbirthweight infant before andafter treatment withindomethacin

J. Brady, H. Halliday, T. Hirata, 2011 .

Postnatal steroids: A dilemma for the neonatologist

H. Halliday, 2001, Acta paediatrica.

Towards earlier neonatal extubation

H. Halliday, 2000, The Lancet.

Cimetidine in labour: absence of adverse effect on the high‐risk fetus

J. Dundee, H. Halliday, J. Moore, 1985, British journal of obstetrics and gynaecology.

The present status of exogenous surfactant for the newborn.

A. Curley, H. Halliday, H. Halliday, 2001, Early human development.

Characterization of the C‐terminal region of molecular forms of human milk bile salt‐stimulated lipase

H. Halliday, A. McKillop, J. Craig, 2004, Acta paediatrica.

Intracerebral haemorrhages in surfactant treated neonates with severe respiratory distress syndrome: age at diagnosis, severity and risk factors

O. Gefeller, H. Halliday, B. Robertson, 1994, European Journal of Pediatrics.